QGEN
nanPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #238
- Final score
- 59.67
- Years on list
- 6
↗ Climbed 247 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- QGEN· nan
- WAT· Waters Corporation
- REGN· Regeneron Pharmaceuticals, Inc.
Figure 01 · Side-by-side summary
The headline numbers
WAT
Waters CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #213
- Final score
- 61.03
- Years on list
- 6
↗ Climbed 106 since 2020
REGN
Regeneron Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #240
- Final score
- 59.63
- Years on list
- 6
↘ Down 124 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | QGEN | WAT | REGN |
|---|---|---|---|
| Climate Change | 77.6 | 74.8 | 72.3 |
| Employee Relations | 53.9 | 47.2 | 54.1 |
| Environment | 57.2 | 64.4 | 59.1 |
| Stakeholders & Society | 45.6 | 80.6 | 61.1 |
| Human Rights | 59.0 | 42.2 | 41.8 |
| Governance | 54.5 | 47.2 | 55.2 |
| Performance Rating | 64.4 | 55.2 | 73.0 |